16-78109710-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016373.4(WWOX):​c.173-68C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.48 in 1,570,608 control chromosomes in the GnomAD database, including 186,219 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 14551 hom., cov: 28)
Exomes 𝑓: 0.49 ( 171668 hom. )

Consequence

WWOX
NM_016373.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.23

Publications

9 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-78109710-C-T is Benign according to our data. Variant chr16-78109710-C-T is described in ClinVar as Benign. ClinVar VariationId is 1295626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.612 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WWOXNM_016373.4 linkc.173-68C>T intron_variant Intron 2 of 8 ENST00000566780.6 NP_057457.1 Q9NZC7-1A0A411HBC7
WWOXNM_001291997.2 linkc.-167-68C>T intron_variant Intron 1 of 7 NP_001278926.1 Q9NZC7
WWOXNM_130791.5 linkc.173-68C>T intron_variant Intron 2 of 5 NP_570607.1 Q9NZC7-3
WWOXNR_120436.3 linkn.412-68C>T intron_variant Intron 2 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WWOXENST00000566780.6 linkc.173-68C>T intron_variant Intron 2 of 8 1 NM_016373.4 ENSP00000457230.1 Q9NZC7-1

Frequencies

GnomAD3 genomes
AF:
0.419
AC:
63225
AN:
150972
Hom.:
14537
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.224
Gnomad AMI
AF:
0.478
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.629
Gnomad SAS
AF:
0.563
Gnomad FIN
AF:
0.441
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.477
Gnomad OTH
AF:
0.470
GnomAD4 exome
AF:
0.487
AC:
691229
AN:
1419520
Hom.:
171668
AF XY:
0.490
AC XY:
347020
AN XY:
708732
show subpopulations
African (AFR)
AF:
0.209
AC:
6819
AN:
32692
American (AMR)
AF:
0.580
AC:
25794
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.474
AC:
12270
AN:
25862
East Asian (EAS)
AF:
0.649
AC:
25597
AN:
39428
South Asian (SAS)
AF:
0.554
AC:
47228
AN:
85298
European-Finnish (FIN)
AF:
0.446
AC:
23728
AN:
53206
Middle Eastern (MID)
AF:
0.508
AC:
2870
AN:
5652
European-Non Finnish (NFE)
AF:
0.483
AC:
518687
AN:
1073864
Other (OTH)
AF:
0.478
AC:
28236
AN:
59018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
17311
34622
51934
69245
86556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15180
30360
45540
60720
75900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.419
AC:
63264
AN:
151088
Hom.:
14551
Cov.:
28
AF XY:
0.423
AC XY:
31215
AN XY:
73748
show subpopulations
African (AFR)
AF:
0.224
AC:
9227
AN:
41282
American (AMR)
AF:
0.537
AC:
8137
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
0.465
AC:
1609
AN:
3462
East Asian (EAS)
AF:
0.630
AC:
3145
AN:
4992
South Asian (SAS)
AF:
0.563
AC:
2664
AN:
4730
European-Finnish (FIN)
AF:
0.441
AC:
4568
AN:
10358
Middle Eastern (MID)
AF:
0.510
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
0.477
AC:
32332
AN:
67806
Other (OTH)
AF:
0.475
AC:
998
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1646
3293
4939
6586
8232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.468
Hom.:
71975
Bravo
AF:
0.416
Asia WGS
AF:
0.618
AC:
2145
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 78% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 73. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.45
DANN
Benign
0.78
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2287972; hg19: chr16-78143607; COSMIC: COSV63434259; API